Increased Indomethacin Dosing for Persistent Patent Ductus Arteriosus in Preterm Infants: A Multicenter, Randomized, Controlled Trial
- 31 August 2008
- journal article
- research article
- Published by Elsevier BV in The Journal of Pediatrics
- Vol. 153 (2), 183-189
- https://doi.org/10.1016/j.jpeds.2008.01.031
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Calcium-dependent and calcium-sensitizing pathways in the mature and immature ductus arteriosusAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2007
- Oxygen-Sensitive Kv Channel Gene Transfer Confers Oxygen Responsiveness to Preterm Rabbit and Remodeled Human Ductus ArteriosusCirculation, 2004
- Low-dose indomethacin therapy and extension of intraventricular hemorrhage: A multicenter randomized trialThe Journal of Pediatrics, 1994
- Prolonged indomethacin therapy for the prevention of recurrences of patent ductus arteriosusThe Journal of Pediatrics, 1990
- Effect of prolonged indomethacin therapy on renal function and selected vasoactive hormones in very-low-birth-weight infants with symptomatic patent ductus arteriosusThe Journal of Pediatrics, 1983
- Effects of indomethacin in premature infants with patent ductus arteriosus: Results of a national collaborative studyThe Journal of Pediatrics, 1983
- The disposition of indomethacin in preterm babiesThe Journal of Pediatrics, 1980
- Plasma indomethacin levels in preterm newborn infants with symptomatic patent ductus arteriosus—clinical and echocardiographic assessments of responseThe Journal of Pediatrics, 1979
- Randomized trial of early closure of symptomatic patent ductus arteriosus in small preterm infantsThe Journal of Pediatrics, 1978
- Incidence and evolution of subependymal and intraventricular hemorrhage: A study of infants with birth weights less than 1,500 gmThe Journal of Pediatrics, 1978